Oxytocin Modulates Eye Gaze Behavior During Social Processing
NCT ID: NCT03293511
Last Updated: 2018-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2017-06-09
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Oxytocin on Affective Touch
NCT03282162
Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses
NCT03610919
The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders
NCT01183221
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors
NCT01944046
Oxytocin Effects on Likeability After Being Liked or Disliked
NCT02745431
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Order of administration: oxytocin - placebo
Participants first receive oxytocin (24 IU). After a washout period of 2 weeks, they receive placebo nasal spray
intranasal oxytocin
24 IU of oxytocin nasal spray will be applied to each subject.
intranasal placebo
24 IU of of placebo nasal spray will be applied to each subject.
Order of administration: placebo - oxytocin
Participants first received placebo nasal spray. After a washout period of 2 weeks, they then receive oxytocin (24 IU).
intranasal oxytocin
24 IU of oxytocin nasal spray will be applied to each subject.
intranasal placebo
24 IU of of placebo nasal spray will be applied to each subject.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intranasal oxytocin
24 IU of oxytocin nasal spray will be applied to each subject.
intranasal placebo
24 IU of of placebo nasal spray will be applied to each subject.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Visual impairments
* Use of medication
* Contraindications for oxytocin administration
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keith Kendrick
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan Kou, MSc
Role: STUDY_CHAIR
University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Le J, Kou J, Zhao W, Fu M, Zhang Y, Becker B, Kendrick KM. Oxytocin Facilitation of Emotional Empathy Is Associated With Increased Eye Gaze Toward the Faces of Individuals in Emotional Contexts. Front Neurosci. 2020 Aug 11;14:803. doi: 10.3389/fnins.2020.00803. eCollection 2020.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESCT_neuSCAN_42
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.